
Insights Lab
Latest insights, research and strategies to help support innovators to achieve real outcomes.
Latest Insights
An important reminder for Australian businesses with a 30 June year financial year that the deadline for lodging your 2023-24 R&D Tax Incentive (RDTI) Application is fast-approaching.
A summary of developments in the world of the R&D Tax Incentive (R&DTI) program from the previous quarter.
Austrade has provided updates for prospective Export Market Development Grant (EMDG) recipients, following the amended application process undertaken in November 2024 for Round 4 of the popular program for Australian SME exporters.
The Australian Federal Government has announced as part of the 2024-25 Mid-Year Economic and Fiscal Outlook that gambling and tobacco companies will no longer be able to access the R&D Tax Incentive. The move is indicative of the government seeking to align public funding with societal objectives, reducing indirect subsidies to industries linked to public harm but raising concerns about future industry-specific restrictions.
Insights into Medical Research Future Fund (MRFF) grant allocation, success rates, and key initiatives over time. As MRFF funding continues to shape the future of health research in Australia, understanding these trends can help applicants refine their strategies and improve their chances of success.
Australia’s public research organisations have showcased their value as innovation partners; achieving over AU$1bn in industry research contracts in 2023, according to the latest Knowledge Commercialisation Australia (KCA) survey.
An important reminder for Australian businesses with a 30 June year financial year that the deadline for lodging your 2023-24 R&D Tax Incentive (RDTI) Application is fast-approaching.
Insights into Medical Research Future Fund (MRFF) grant allocation, success rates, and key initiatives over time. As MRFF funding continues to shape the future of health research in Australia, understanding these trends can help applicants refine their strategies and improve their chances of success.
With the Queensland State Government election fast-approaching, it’s important that any Queensland businesses that are considering applying for state government funding understand what impact the election will have on grant programs. We’ve summarised our analysis of the impact that elections can have on the grant funding landscape, with a particular focus on the Queensland State Government election in October.
The Medical Research Future Fund (MRFF) is a major source of health research funding in Australia, providing opportunities for both researchers and companies. The MRFF publishes funding rounds in advance, giving applicants reasonable notice to prepare. We have prepared an overview of upcoming grant opportunities, eligibility, and how Intellect Labs can support your submission.
Clinical trials have long been viewed favourably under the R&D Tax Incentive Program. To recognise this, the program offers an efficient registration process for trials registered with the Therapeutic Goods Administration, reducing the administrative burden for biotech companies. This streamlined approach, along with support through Advance Overseas Findings (AOF), empowers Australian biotech firms to innovate and lead on the global stage.
The Overseas Finding process is a crucial component of the Research & Development Tax Incentive (RDTI) in Australia, enabling companies to access a tax benefit for overseas activities that relate to an Australian R&D program. This guide explores the Overseas Finding process, the key conditions for eligibility, and recent ATO concerns as outlined in taxpayer alerts. We also highlight a successful case study with a cyber security innovator, Internet 2.0, to illustrate effective strategies for securing an Overseas Finding.
Featured Posts
Featured Grants
A federal government initiative with $150 million of matched funding available for this first round.
Case Studies
Internet 2.0’s case illustrates how a well-prepared Overseas Funding application can lead to significant financial support and increased investor confidence. It underscores the importance of strategic planning and thorough documentation in the R&D tax incentive process.
With the help of the R&D Tax Incentive (‘RDTI’) program, Dataweavers is investing in R&D to deliver innovative solutions for deploying complex enterprise marketing technology and Digital Experience Platforms (DXPs) in the public cloud.
Ridley Corporation is accessing the R&D Tax Incentive (‘RDTI’) to help them drive innovation in Australian agriculture by providing advanced, sustainable animal nutrition solutions that assist farmers to enhance animal health and productivity while reducing environmental impact.
A $5m grant from the Medical Research Future Fund (MRFF) will help Southern RNA combine its new manufacturing capability with the Queensland research community to create an end-to-end mRNA translation ecosystem.
Start-up medical device company Neurode is accessing the Federal Government’s flagship innovation program, the R&D Tax Incentive (‘RDTI’), to improve quality of life for people diagnosed with ADHD.
Great Wrap is on a mission to remove the 150,000 tonnes of plastic stretch wrap sent to Australia’s landfill each year. A $535,000 grant from the Advanced Manufacturing Growth Centre will help them to do just that.
$2.57m from the Federal Government’s flagship manufacturing program will help Cyclowest fast-track production of next generation cancer treatments.